Subscribe To This Blog

Wednesday, June 18, 2014

Hospital Acquired Disease Testing Market Share 2013 - 2019

The global hospital acquired disease testing market was valued at USD 2.2 billionin 2012 and is expected to grow at a CAGR
of 19.3% from 2013 to 2019, to reach an estimated value of USD 7.5 billion in 2019.

Nosocomial infections/hospital acquired
diseases/hospital associated infections (HAI)form one of the critical areas of
focus in the healthcare industry. Factors such as increasing prevalence of such
conditions in neonatal and geriatric population, initiatives taken up by
governments to manage nosocomial infections, increasing number of diseases that
increases risk of hospital associated infections, and growing concerns about
control and prevention of nosocomial infections worldwide will have a
positiveimpact on the current hospital acquired disease testing industry.

The global hospital acquired disease testing market is
segmented on the basis of type of infection and geography. Based on the
different typesof infection,this market is classified into pneumonia, urinary
tract infection, blood stream infection, surgical site associated infection,
MRSA infection testing and others. The hospital acquired urinary tract
infection diagnostics segment occupies the largest market share in this
category as prevalence and morbidity rate of this condition, and the demand for
diagnostic solutions for the same is the highest as compared to other hospital
associated infections. It is expected that the global market for hospital
associated urinary tract infection testing will reach USD
2,188.8 million in 2019 with the market growing at CAGR of 18.1%from
2013 to 2019.

Furthermore, other testing solutions for conditions such as surgical
site infections and pneumonia (hospital associated and ventilator associated
infections) will also experience high demand in lesser developed regions of Asia-Pacific, Latin America
and other developing countries where the prevalence of such conditions is
higher. It is expected that the market for surgical site infections will grow
at a CAGR of 20.1%during the given period of forecast.

Geographically, United States
and Canada together are the leaders inthe global
hospital acquired disease testing market with a combined market share (of the
North American region) of 41.3% in 2012. Some of the major growth drivers for
the North American nosocomial infection testing market include existence of
highly developed healthcare infrastructure, high rate of implementation of
healthcare guidelines given by regulatory and guiding institutions such as
Centers for Disease Control and Prevention (U.S.), and increasing awareness
about these diseases and their prevention.

The European Union considers
infectious diseases as an increasing threat to the general public health; the
public health system in this region is increasingly engaging itself in
conducting dialogue between healthcare providers and medical practitioners for
developing better, faster and cost effective methods for nosocomial infection
management and prevention. Asian countries including China,
Philippines and India
are the most potential markets for such diagnostic and testing solutions owing
to existence of factors such as higher population, poor hospital
infrastructure, lack of adherence to sanitation procedures and thereforehigher
disease prevalence growth rates. UAE and African countries are some of the
lucrative markets in the Rest of the World (RoW).

Molecular diagnostics solutions play a vital role in
this market as they offer precise, faster and cost effective diagnosis for
various nosocomial infections. Considering the market competition, the global
hospital acquired infection testing market is highly fragmented and is
characterized by the existence of several large and mid-sized diagnostic
solution providers. Some of the key market players contributing to this
industry include Diatherix Laboratories Inc., Gen-Probe Inc., Qiagen GmbH, L
Hoffman La Roche,Cepheid, Inc.,Life Technologies Corporation, Meridian
Biosciences, Cantel Medical Corporation, Nordion, Inc. and others.

Transparency Market Research is a
global market intelligence company, providing global business information
reports and services. Our exclusive blend of quantitative forecasting and
trends analysis provides forward-looking insight for thousands of decision
makers. We are privileged with highly experienced team of Analysts,
Researchers, and Consultants, who use proprietary data sources and various tools
and techniques to gather, and analyze information.

Our data repository is continuously
updated and revised by a team of research experts, so that it always reflects
the latest trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary and secondary
research techniques in developing distinctive data sets and research material
for business reports.